Medicina anti-aging: attualità e prospettive future

Dermakos 2017; 4: 44-50

Bibliografia

1. Bloom DE, Chatterji S, Kowal P, Lloyd-Sherlock P, McKee M et al 2015. Macroeconomic implications of population ageing and selected policy responses. Lancet; 385:649–657.
2. Hung WW, Ross JS, Boockvar KS, Siu AL. Recent trends in chronic disease,impairment and disability among older adults in the United States. BMC Geriatr.2011 Aug 18;11:47.
3. Vaiserman AM, Marotta F. Longevity-Promoting Pharmaceuticals: Is it a time for implementation? Trends Pharmacol Sci. 2016 May;37(5):331-3
4. Faragher RG. Should we treat aging as a disease? The consequences and dangers of miscategorisation. Front Genet. 2015 Jul 14;6:171
5. Zhavoronkov A, Moskalev A. Editorial: Should We Treat Aging as a Disease? Academic, Pharmaceutical, Healthcare Policy, and Pension Fund Perspectives. Front Genet. 2016 Feb 16;7:17.
6. Seals DR, Justice JN, LaRocca TJ. Physiological geroscience: targeting function to increase healthspan and achieve optimal longevity. J Physiol. 2016 Apr 15;594(8):2001-24
7. Sierra F, Kohanski R. Geroscience and the trans-NIH Geroscience Interest Group, GSIG. Geroscience. 2017 Feb;39(1):1-5
8. Melov S. Geroscience approaches to increase healthspan and slow aging. F1000Res. 2016 Apr 29;5. pii: F1000 Faculty Rev-785
9. Martin GM. Geroscience: Addressing the mismatch between its exciting research opportunities, its economic imperative and its current funding crisis. Exp Gerontol. 2017 Aug;94:46-51
10. Franceschi C, Garagnani P. Suggestions from Geroscience for the genetics of age-related diseases. PLoS Genet. 2016 Nov 10;12(11):e1006399
11. Burch JB, Augustine AD, Frieden LA, Hadley E, Howcroft TK et al. Advances in geroscience: impact on healthspan and chronic disease. J Gerontol A Biol Sci Med Sci. 2014 Jun;69 Suppl 1:S1-3
12. Kennedy BK, Berger SL, Brunet A, Campisi J, Cuervo AM et al. Geroscience: linking aging to chronic disease. Cell. 2014 Nov 6;159(4):709-13
13. Partridge, L.. Intervening in ageing to prevent the diseases of ageing. Trends Endocrinol. Metab. 2014;25:555–557.
14. Longo VD, Antebi A, Bartke A, Barzilai N, Brown-Borg HM et al., 2015. Interventions to slow aging in humans: are we ready? Aging Cell 14, 497–510
15. de Magalhães JP, Stevens M, Thornton D. The Business of Anti-Aging Science. Trends Biotechnol. 2017 Aug 1. pii: S0167-7799(17)30171-3
16. Goldman D. The Economic Promise of Delayed Aging. Cold Spring Harb Perspect Med. 2015 Dec 18;6(2):a025072
17. Laura Lorenzetti. The obsession with ‘curing’ aging is now big business. Fortune Mar 07, 2016
18. Pollack A, Miller CC. “Tech titans form biotechnology company”. New York Times. 18 September 2013
19. Wang GD, Lai DJ, Burau KD, Du XL. Potential gains in life expectancy from reducing heart disease, cancer, Alzheimer’s disease, kidney disease or HIV/AIDS as major causes of death in the USA. Public Health. 2013 Apr;127(4):348-56
20. Stenvinkel P, Kooman JP, Shiels PG. Nutrients and ageing: what can we learn about ageing interactions from animal biology? Curr Opin Clin Nutr Metab Care. 2016 Jan;19(1):19-25
21. Vaiserman AM, Lushchak OV, Koliada AK. Anti-aging pharmacology: Promises and pitfalls. Ageing Res Rev. 2016 Nov;31:9-35
22. Kumar S, Lombard DB. Finding Ponce de Leon’s pill: challenges in screening for anti-aging molecules. F1000Res. 2016 Mar 29;5. pii: F1000 Faculty Rev-406
23. Albin RL, Miller RA. Mini-review: Retarding aging in murine genetic models of neurodegeneration. Neurobiol Dis. 2016 Jan;85:73-80
24. Vanhooren V, Libert C. The mouse as a model organism in aging research: usefulness, pitfalls and possibilities. Ageing Res Rev. 2013 Jan;12(1):8-21
25. Yuan R, Peters LL, Paigen B. Mice as a mammalian model for research on the genetics of aging. ILAR J. 2011;52(1):4-15
26. Mohammadi D, Davis N Can this woman cure ageing with gene therapy?. Biotech boss Elizabeth Parrish has tried out her company’s anti-ageing gene therapy with, she says, amazing results. Too good to be true. The Observer Sunday 24 July 2016
27. Grens K | First Data from Anti-Aging Gene Therapy. A biotech company reports that an experimental treatment elongated its CEO’s telomeres. The Scientist April 25, 2016
28. Strazhesko ID, Tkacheva ON, Akasheva DU, Dudinskaya EN, Plokhova EV et al. Atorvastatin therapy modulates telomerase activity in patients free of atherosclerotic ccardiovascular diseases. Front Pharmacol. 2016 Sep 30;7:347
29. Harrison DE, Strong R, Allison DB, Ames BN, Astle CM et al. Acarbose,17-α-estradiol and nordihydroguaiaretic acid extend mouse lifespan preferentially in males. Aging Cell 2014;13:273–282.
30. Benigni A, Orisio S, Noris M, Iatropoulos P, Castaldi D, et al. Variations of the angiotensin II type 1 receptor gene are associated with extreme human longevity. Age(Dordr.) 2013;35:993–1005
31. Colón-Emeric CS, Mesenbrink P, Lyles KW, Pieper CF, Boonen S et al. Potential mediators of the mortality reduction with zoledronic acid after hip fracture. J Bone Miner Res. 2010;25:91–97.
32. Strong R, Miller RA, Astle CM, Floyd RA, Flurkey K et al. Nordihydroguaiaretic acid and aspirin increase lifespan of genetically heterogeneous male mice. Aging Cell. 2008;7:641–650
33. Voss G. The Risks of Anti-Aging Medicine. http://www.health.com/health/article/0,,20544045,00.html. Health Magazine April 18, 2012
34. Heinrich J. United States General Accounting Office. Potential Harm From “Anti-Aging” Products. Testimony Before the Special Committee on Aging, U.S. Senate. September 10, 2001. http://www.gao.gov/new.items/d011139t.pdf
35. Perls TT. Anti-aging quackery: human growth hormone and tricks of the trade–more dangerous than ever. J Gerontol A Biol Sci Med Sci. 2004 Jul;59(7):682-91
36. Berezow A. Call junk science by its rightful name: fake news. USA today.2017 https://www.usatoday.com/story/opinion/2017/07/21/its-time-call-out-fake-news-health-industry-column/466416001/
37. Austad SN. Bad science makes big headlines. Huffingtonpost Feb 09, 2017 http://www.huffingtonpost.com/american-federation-for-aging-research/bad-science-makes-big-hea_b_14602532.html
38. Austin SB, Yu K, Liu SH, Dong F, Tefft N. Household expenditures on dietary supplements sold for weight loss, muscle building, and sexual function: Disproportionate burden by gender and income. Prev Med Rep. 2017 Mar 24;6:236-241
39. Sadovsky R, Collins N, Tighe AP, Brunton SA, Safeer R. Patient use of dietary supplements: a clinician’s perspective. Curr Med Res Opin. 2008 Apr;24(4):1209-16
40. Pillitteri JL, Shiffman S, Rohay JM, Harkins AM, Burton SL, Wadden TA. Use of dietary supplements for weight loss in the United States: results of a national survey. Obesity (Silver Spring). 2008 Apr;16(4):790-6
41. Brennan R, Wells JS, Van Hout MC. The injecting use of image and performance-enhancing drugs (IPED) in the general population: a systematic review. Health Soc Care Community. 2016 Jan 25. doi: 10.1111/hsc.12326
42. Royne MB, Myers SD, Deitz G, Fox AK . Risks, benefits, and competitive interference: consumer perceptions of prescription drug versus dietary supplement advertising. J Current Issues & Research in Advertising 2016;37:59-79
43. Drazen JM. Inappropriate advertising of dietary supplements. N Engl J Med 2003; 348:777-778
44 Mehlman MJ, Binstock RH, Juengst ET, Ponsaran RS, Whitehouse PJ. Anti-aging medicine: can consumers be better protected? Gerontologist. 2004 Jun;44(3):304-10
45. Blumberg J, Heaney RP, Huncharek M, Scholl T, Stampfer M et al. Evidence-based criteria in the nutritional context. Nutr Rev. 2010 Aug;68(8):478-84
46. Barzilai N, Crandall JP, Kritchevsky SB, Espeland MA. Metformin as a Tool to Target Aging. Cell Metab. 2016 Jun 14;23(6):1060-5
47. Bannister CA, Holden SE, Jenkins-Jones S, Morgan CL, Halcox JP et al. Can people with type 2 diabetes live longer than those without? A comparison of mortality in people initiated with metformin or sulphonylurea monotherapy and matched, non-diabetic controls. Diabetes Obes Metab. 2014 Nov;16(11):1165-73
48. Espeland MA, Crimmins EM, Grossardt BR, Crandall JP, Gelfond JA et al. Clinical trials targeting aging and age-related multimorbidity. J Gerontol A Biol Sci Med Sci. 2017 Mar 1;72(3):355-361
49. Chen BH, Marioni RE, Colicino E, Peters MJ, Ward-Caviness CKet al. DNA methylation-based measures of biological age: meta-analysis predicting time to death. Aging (Albany NY). 2016 Sep 28;8(9):1844-1865
50. Cheng S, Larson MG, McCabe EL, Murabito JM, Rhee EP et al. Distinct metabolomics signatures are associated with longevity in humans. Nat Commun. 2015 Apr 13;6:6791
51. Horvath S. DNA methylation age of human tissues and cell types. Genome Biol. 2013;14:R115
52. Sebastiani P, Thyagarajan B, Sun F, Schupf N, Newman AB, Montano M, Perls TT. Biomarker signatures of aging. Aging Cell. 2017 Apr;16(2):329-338
53. Burd CE, Gill MS, Niedernhofer LJ, Robbins PD, Austad SN, Barzilai N, Kirkland JL. Barriers to the preclinical development of therapeutics that target aging mechanisms. J Gerontol A Biol Sci Med Sci. 2016 Nov;71(11):1388-1394
54. Niedernhofer LJ, Kirkland JL, Ladiges W. Molecular pathology endpoints useful for aging studies. Ageing Res Rev. 2017 May;35:241-249
55. Newman JC, Milman S, Hashmi SK, Austad SN, Kirkland JL et al. Strategies and challenges in clinical trials targeting human Aaging. J Gerontol A Biol Sci Med Sci. 2016 Nov;71(11):1424-1434
56. Huffman DM, Justice JN, Stout MB, Kirkland JL, Barzilai N, Austad SN. Evaluating health span in preclinical models of aging and disease: guidelines, challenges, and opportunities for geroscience. J Gerontol A Biol Sci Med Sci. 2016 Nov;71(11):1395-1406
57. Woolf SH. The meaning of translational research and why it matters. JAMA. 2008 Jan 9;299(2):211-3
58. Moskalev A, Anisimov V, Aliper A, Artemov A, Asadullah K et al. A review of the biomedical innovations for healthy longevity. Aging (Albany NY). 2017 Jan 29;9(1):7-25
59. Mykytyn CE. A history of the future: the emergence of contemporary anti-ageing medicine. Sociol Health Illn. 2010 Feb 1;32(2):181-96
60. Mykytyn CE. Anti-aging medicine: a patient/practitioner movement to redefine aging. Soc Sci Med. 2006 Feb;62(3):643-53
61. Bartoletti CA, Riondino G, Veraldi M, Romanelli F, Palmieri G, Bartoletti E, Terranova F. Medicina Estetica e Medicina Anti-aging. La Medicina Estetica Salus Ed. Italy. 2006;30(2):279-294
62. Kaeberlein M, Rabinovitch PS, Martin GM. Healthy aging: The ultimate preventative medicine. Science. 2015 Dec 4;350(6265):1191-3
63. Seals DR, Justice JN, LaRocca TJ. Physiological geroscience: targeting function to increase healthspan and achieve optimal longevity. J Physiol. 2016 Apr 15;594(8):2001-24
64. van den Berg N, Beekman M, Smith KR, Janssens A, Slagboom PE. Historical demography and longevity genetics: Back to the future. Ageing Res Rev. 2017 Sep;38:28-39
65. Hole B, Salem J. How long do patients with chronic disease expect to live? A systematic review of the literature. Clin Med (Lond). 2016 Jun 1;16 Suppl 3:s32
66. Yashin AI, Arbeev KG, Arbeeva LS, Wu D, Akushevich I et al. How the effects of aging and stresses of life are integrated in mortality rates: insights for genetic studies of human health and longevity. Biogerontology. 2016 Feb;17(1):89-107
67. Govindaraju D, Atzmon G, Barzilai N. Genetics, lifestyle and longevity: Lessons from centenarians. Appl Transl Genom. 2015 Feb 4;4:23-32
68. Robert L, Fulop T. Longevity and its regulation: centenarians and beyond.Interdiscip Top Gerontol. 2014;39:198-211
69. Monti D, Ostan R, Borelli V, Castellani G, Franceschi C. Inflammaging and human longevity in the omics era. Mech Ageing Dev. 2016 Dec 27. pii: S0047-6374(16)30261-5
70. Willcox BJ, Willcox DC, Ferrucci L. Secrets of healthy aging and longevity from exceptional survivors around the globe: lessons from octogenarians to supercentenarians. J Gerontol A Biol Sci Med Sci. 2008 Nov;63(11):1181-5
71. Kohanski RA, Deeks SG, Gravekamp C, Halter JB, High K et al. Reverse geroscience: how does exposure to early diseases accelerate the age-related decline in health? Ann N Y Acad Sci. 2016 Dec;1386(1):30-44
72. Hodes RJ, Sierra F, Austad SN, Epel E, Neigh GN et al. Disease drivers of aging. Ann N Y Acad Sci. 2016 Dec;1386(1):45-68
73. Franceschi C, Campisi J. Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. J Gerontol A Biol Sci Med Sci. 2014 Jun;69 Suppl 1:S4-9
74. Kimokoti RW, Millen BE. Nutrition for the prevention of chronic diseases. Med Clin North Am. 2016 Nov;100(6):1185-1198
7.5 Ornish D. It’s time to embrace lifestyle medicine. Time. 2015 Feb 23-Mar 2;185(6-7):97
76. Phillips E, Pojednic R, Polak R, Bush J, Trilk J. Including lifestyle medicine in undergraduate medical curricula. Med Educ Online. 2015 Feb 3;20:26150
77. Malatskey L, Bar Zeev Y, Tzuk-Onn A, Polak R. Lifestyle medicine course for family medicine residents: preliminary assessment of the impact on knowledge, attitudes, self-efficacy and personal health. Postgrad Med J. 2017 Mar 13. pii: postgradmedj-2016-134726
78. Polak R, Shani M, Dacey M, Tzuk-Onn A, Dagan I, Malatskey L. Family physicians prescribing lifestyle medicine: feasibility of a national training programme. Postgrad Med J. 2016 Jun;92(1088):312-7
79 Luo J, Wu M, Gopukumar D, Zhao Y. Big Data Application in Biomedical Research and Health Care: A Literature Review. Biomed Inform Insights. 2016 Jan 19;8:1-10
80. Opap K, Mulder N. Recent advances in predicting gene-disease associations. F1000Res. 2017 Apr 26;6:578
81. Feero WG, Guttmacher AE, Collins FS. Genomic medicine—an updated primer. N Engl J Med. 2010;362:2001–2011
82. Moszyńska A, Gebert M, Collawn JF, Bartoszewski R. SNPs in microRNA target sites and their potential role in human disease. Open Biol. 2017 Apr;7(4). pii:170019
83. Zhang F, Lupski JR. Non-coding genetic variants in human disease. Hum Mol Genet. 2015 Oct 15;24(R1):R102-10
84. Ng PC, Henikoff S. Predicting the effects of amino acid substitutions on protein function. Annu Rev Genomics Hum Genet. 2006;7:61-80
85 Welter D, MacArthur J, Morales J, Burdett T, Hall P, Junkins H, et al. The NHGRI GWAS catalog, a curated resource of snp-trait associations.Nucleic Acids Res. 2014;42:D1001–6
86. Ford D, Easton DF, Stratton M, Narod S, Goldgar D et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. Am J Hum Genet. 1998 Mar;62(3):676-89
87. King MC, Marks JH, Mandell JB; New York Breast Cancer Study Group. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science. 2003 Oct 24;302(5645):643-6
88. Price AL, Spencer CC, Donnelly P. Progress and promise in understanding the genetic basis of common diseases. Proc Biol Sci. 2015 Dec 22;282(1821):20151684
89. Morgan TM, Krumholz HM, Lifton RP, Spertus JA. Nonvalidation of reported genetic risk factors for acute coronary syndrome in a large-scale replication study. JAMA. 2007;297:1551-156
90. Maher BS. Polygenic Scores in Epidemiology: Risk Prediction, Etiology, and Clinical Utility. Curr Epidemiol Rep. 2015; 2(4): 239–244
91. Kong SW, Lee IH, Leshchiner I, Krier J, Kraft P, et al; MedSeq Project. Summarizing polygenic risks for complex diseases in a clinical whole-genome report. Genet Med. 2015 Jul;17(7):536-44
92. Desikan RS, Fan CC, Wang Y, Schork AJ, Cabral HJ et al. Genetic assessment of age-associated Alzheimer disease risk: Development and validation of a polygenic hazard score. PLoS Med. 2017 Mar 21;14(3):e1002258
93. https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm551185.htm
94. Kolata G. FDA will allow Me to sell genetic tests for disease risk to consumers. New York Times April 6 2017
95. Luizon MR, Ahituv N. Uncovering drug-responsive regulatory elements. Pharmacogenomics. 2015;16(16): 1829-41
96. Turner RM, Park BK, Pirmohamed M. Parsing interindividual drug variability: an emerging role for systems pharmacology. Wiley Interdiscip Rev Syst Biol Med. 2015 Jul-Aug;7(4):221-41
97. Chan SL, Jin S, Loh M, Brunham LR. Progress in understanding the genomic basis for adverse drug reactions: a comprehensive review and focus on the role of ethnicity. Pharmacogenomics. 2015;16(10):1161-78
98. Rodríguez-Antona C, Taron M. Pharmacogenomic biomarkers for personalized cancer treatment. J Intern Med. 2015 Feb;277(2):201-17
99. Sales NM, Pelegrini PB, Goersch MC. Nutrigenomics: definitions and advances of this new science. J Nutr Metab. 2014;2014:202759
100. Rescigno T, Micolucci L, Tecce MF, Capasso A. Bioactive Nutrients and Nutrigenomics in Age-Related Diseases. Molecules. 2017 Jan 8;22(1). pii: E105
101. San-Cristobal R, Milagro FI, Martínez JA. Future challenges and present ethical considerations in the use of personalized nutrition based on genetic advice. J Acad Nutr Diet. 2013 Nov;113(11):1447-54
102. Perez-Martinez P, Phillips CM, Delgado-Lista J, Garcia-Rios A, Lopez-Miranda J, Perez-Jimenez F. Nutrigenetics, metabolic syndrome risk and personalized nutrition. Curr Vasc Pharmacol. 2013 Nov;11(6):946-53
103. Subbiah MT. Nutrigenetics and nutraceuticals: the next wave riding on personalized medicine. Transl Res. 2007; 149(2): 55-61
104. Jylhävä J, Pedersen NL, Hägg S. Biological Age Predictors. EBioMedicine. 2017 Jul;21:29-36
105. Victorelli S, Passos JF. Telomeres and Cell Senescence – Size Matters Not. EBioMedicine. 2017 Jul;21:14-20
106. Breitling LP, Saum KU, Perna L, Schöttker B, Holleczek B, Brenner H. Frailty is associated with the epigenetic clock but not with telomere length in a German cohort. Clin Epigenetics. 2016 Feb 26;8:21
107. Horvath S. DNA methylation age of human tissues and cell types. Genome Biol.2013;14(10):R115
108. Armstrong NJ, Mather KA, Thalamuthu A, Wright MJ, Trollor JN et al. Aging, exceptional longevity and comparisons of the Hannum and Horvath epigenetic clocks. Epigenomics. 2017 May;9(5):689-700
109. Freire-Aradas A, Phillips C, Lareu MV. Forensic individual age estimation with DNA: From initial approaches to methylation tests. Forensic Sci Rev. 2017 Jul;29(2):121-144
110. Kwon D. Company Sells a “Biological Age” Kit. The Scientist 2017 August 2, http://www.the-scientist.com/?articles.view/articleNo/50011/title/Company-Sells-a–Biological-Age–Kit/
111. Peters MJ, Joehanes R, Pilling LC, Schurmann C, Conneely KN et al. The transcriptional landscape of age in human peripheral blood. Nat Commun. 2015 Oct 22;6:8570.
112. Nkuipou-Kenfack E, Koeck T, Mischak H, Pich A, Schanstra JP et al. Proteome analysis in the assessment of ageing. Ageing Res Rev. 2014 Nov;18:74-85
113. Hertel J, Friedrich N, Wittfeld K, Pietzner M, Budde K et al. Measuring biological age via Metabonomics: the metabolic age score. J. Proteome Res. 2016; 15: 400–410
114. Sebastiani P, Thyagarajan B, Sun F, Schupf N, Newman AB et al. Biomarker signatures of aging .Aging Cell 2017; 16(2):329–338.
115. Belsky DW, Caspi A, Houts R, Cohen HJ, Corcoran DL et al. Quantification of biological aging in young adults. Proc Natl Acad Sci U S A. 2015 Jul 28;112(30):E4104-10
116. Kim S, Myers L, Wyckoff J, Cherry KE, Jazwinski SM. The frailty index outperforms DNA methylation age and its derivatives as an indicator of biological age. Geroscience. 2017 Feb;39(1):83-92
117. Kim S, Jazwinski SM (2015) Quantitative measures of healthy aging and biological age. Healthy Aging Res 4:26. doi:10.12715/har.2015.4.26
118. Jaspers L, Schoufour JD, Erler NS, Darweesh SK, Portegies ML. Development of a Healthy Aging Score in the population-based Rotterdam Study: evaluating age and sex differences. J Am Med Dir Assoc. 2017 Mar 1;18(3):276.e1-276.e7
119. Al-Regaiey KA. The effects of calorie restriction on aging: a brief review. Eur Rev Med Pharmacol Sci. 2016 Jun;20(11):2468-73
120. Azzu V, Valencak TG. Energy Metabolism and Ageing in the Mouse: A Mini-Review. Gerontology. 2017 Jan 25. doi: 10.1159/000454924. [Epub ahead of print]
121. Yamada Y, Kemnitz JW, Weindruch R, Anderson RM, Schoeller DA, Colman RJ. Caloric restriction and healthy life span: frail phenotype of nonhuman primates in the Wisconsin National Primate Research Center Caloric Restriction Study. J Gerontol A Biol Sci Med Sci. 2017 Apr 8. doi: 10.1093/gerona/glx059. [Epub ahead of print]
122. Kemnitz JW. Calorie restriction and aging in nonhuman primates. ILAR J. 2011;52(1):66-77.
123. Most J, Tosti V, Redman LM, Fontana L. Calorie restriction in humans: An update. Ageing Res Rev. 2016 Aug 17. pii: S1568-1637(16)30183-0
124. Mattison JA, Colman RJ, Beasley TM, Allison DB, Kemnitz JW et al. Caloric restriction improves health and survival of rhesus monkeys. Nat Commun. 2017 Jan 17;8:14063
125. Rizza W, Veronese N, Fontana L. What are the roles of calorie restriction and diet quality in promoting healthy longevity? Ageing Res Rev. 2014 Jan;13:38-45
126. Prospective Studies Collaboration, Whitlock G, Lewington S, Sherliker P, Clarke R, Emberson J et al. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet. 2009 Mar 28;373(9669):1083-96
127. Abraham KJ, Ostrowski LA, Mekhail K. Non-coding RNA molecules connect calorie restriction and lifespan. J Mol Biol. 2016 Aug 22. pii: S0022-2836(16)30334-5
128. Chung KW, Kim DH, Park MH, Choi YJ, Kim ND, Lee J, Yu BP, Chung HY. Recent advances in calorie restriction research on aging. Exp Gerontol. 2013 Oct;48(10):1049-53
129. Abete I, Navas-Carretero S, Marti A, Martinez JA. Nutrigenetics and nutrigenomics of caloric restriction. Prog Mol Biol Transl Sci. 2012;108:323-46
130. Park SK, Prolla TA. Lessons learned from gene expression profile studies of aging and caloric restriction. Ageing Res Rev. 2005 Jan;4(1):55-65
131. Kim DH, Park MH, Lee EK, Choi YJ, Chung KW et al. The roles of FoxOs in modulation of aging by calorie restriction. Biogerontology. 2015 Feb;16(1):1-14
132. López-Lluch G, Navas P. Calorie restriction as an intervention in ageing. J Physiol. 2016;594(8):2043-60
133. Luo H, Chiang HH, Louw M, Susanto A, Chen D. Nutrient Sensing and the Oxidative Stress Response. Trends Endocrinol Metab. 2017 Mar 14. pii: S1043-2760(17)30025-5
134. Clarys P, Deliens T, Huybrechts I, Deriemaeker P, Vanaelst B, De Keyzer W, Hebbelinck M, Mullie P. Comparison of nutritional quality of the vegan, vegetarian, semi-vegetarian, pesco-vegetarian and omnivorous diet. Nutrients. 2014 Mar 24;6(3):1318-32
135. Turner-McGrievy G, Harris M. Key elements of plant-based diets associated with reduced risk of metabolic syndrome. Curr Diab Rep. 2014;14(9):524
136. Mattson MP, Longo VD, Harvie M. Impact of intermittent fasting on health and disease processes. Ageing Res Rev. 2016 Oct 31. pii: S1568-1637(16)30251-3
137. Harvie M, Howell A. Potential benefits and harms of intermittent energy restriction and intermittent fasting amongst obese, overweight and normal weight subjects-A narrative review of human and animal evidence. Behav Sci (Basel). 2017 Jan 19;7(1). pii: E4
138. Brandhorst S, Choi IY, Wei M, Cheng CW, Sedrakyan S, Longo VD et al. A periodic diet that mimics fasting promotes multi-system regeneration, enhanced cognitive performance, and healthspan. Cell Metab. 2015 Jul 7;22(1):86-99
139. Le Couteur DG, Solon-Biet S, Cogger VC, Mitchell SJ, Senior A, de Cabo R, Raubenheimer D, Simpson SJ. The impact of low-protein high-carbohydrate diets on aging and lifespan. Cell Mol Life Sci. 2016 Mar;73(6):1237-52
140. Mirzaei H, Suarez JA, Longo VD. Protein and amino acid restriction, aging and disease: from yeast to humans. Trends Endocrinol Metab. 2014 Nov;25(11):558-66
141. Lee BC, Kaya A, Gladyshev VN. Methionine restriction and life-span control. Ann N Y Acad Sci. 2016 Jan;1363:116-24
142. McIsaac RS, Lewis KN, Gibney PA, Buffenstein R. From yeast to human: exploring the comparative biology of methionine restriction in extending eukaryotic life span. Ann N Y Acad Sci. 2016 Jan;1363:155-70
143. Mirzaei H, Suarez JA, Longo VD. Protein and amino acid restriction, aging and disease: from yeast to humans. Trends Endocrinol Metab. 2014 Nov;25(11):558-66
144. Coombs N, Stamatakis E, Lee IM. Physical inactivity among older adults: Implications for life expectancy among non-overweight and overweight or obese individuals. Obes Res Clin Pract. 2015 Mar-Apr;9(2):175-9
145. Chantranupong L, Wolfson RL, Sabatini DM. Nutrient-sensing mechanisms across evolution. Cell. 2015 Mar 26;161(1):67-83
146. Loper HB, La Sala M, Dotson C, Steinle N. Taste perception, associated hormonal modulation, and nutrient intake. Nutr Rev. 2015 Feb;73(2):83-91
147. Kishida K, Pearce SC, Yu S, Gao N, Ferraris RP. Nutrient sensing by absorptive and secretory progenies of small intestinal stem cells. Am J Physiol Gastrointest Liver Physiol. 2017 Jun 1;312(6):G592-G60
148. Karra E, Batterham RL. The role of gut hormones in the regulation of body weight and energy homeostasis. Mol Cell Endocrinol. 2010 Mar 25;316(2):120-8
149. Mathew R, Pal Bhadra M, Bhadra U. Insulin/insulin-like growth factor-1 signalling (IIS) based regulation of lifespan across species. Biogerontology. 2017 Feb;18(1):35-53
150. Efeyan A, Comb WC, Sabatini DM. Nutrient-sensing mechanisms and pathways. Nature. 2015 Jan 15;517(7534):302-10.
151. González A, Hall MN. Nutrient sensing and TOR signaling in yeast and mammals. EMBO J. 2017 Feb 15;36(4):397-408
152. Howell JJ, Manning BD. mTOR couples cellular nutrient sensing to organismal metabolic homeostasis. Trends Endocrinol Metab. 2011 Mar;22(3):94-102
153. Burkewitz K, Zhang Y, Mair WB. AMPK at the nexus of energetics and aging. Cell Metab. 2014 Jul 1;20(1):10-25
154. Grabowska W, Sikora E, Bielak-Zmijewska A. Sirtuins, a promising target in slowing down the ageing process. Biogerontology. 2017 Mar 3. doi: 10.1007/s10522-017-9685-9. [Epub ahead of print]
155. Yang Y, Sauve AA. NAD(+) metabolism: Bioenergetics, signaling and manipulation for therapy. Biochim Biophys Acta. 2016 Dec;1864(12):1787-1800
156. Bettedi L, Foukas LC. Growth factor, energy and nutrient sensing signalling pathways in metabolic ageing. Biogerontology. 2017 Aug 9. doi: 10.1007/s10522-017-9724-6. [Epub ahead of print]
157. Luo H, Chiang HH, Louw M, Susanto A, Chen D. Nutrient Sensing and the Oxidative Stress Response. Trends Endocrinol Metab. 2017 Jun;28(6):449-460
158. Dilova I, Easlon E, Lin SJ. Calorie restriction and the nutrient sensing signaling pathways. Cell Mol Life Sci. 2007 Mar;64(6):752-67
159. Handschin C. Caloric restriction and exercise “mimetics”: Ready for prime time? Pharmacol Res. 2016 Jan;103:158-66
160. Cetrullo S, D’Adamo S, Tantini B, Borzi RM, Flamigni F. mTOR, AMPK, and Sirt1: Key Players in Metabolic Stress Management. Crit Rev Eukaryot Gene Expr.2015;25(1):59-75
161. Kitada M, Koya D. The use of calorie restriction mimetics to study aging. Methods Mol Biol. 2013;1048:95-107
162. Roth GS, Ingram DK. Manipulation of health span and function by dietary caloric restriction mimetics. Ann N Y Acad Sci. 2016 Jan;1363:5-10
163. Munson MJ, Ganley IG. MTOR, PIK3C3, and autophagy: Signaling the beginning from the end. Autophagy. 2015;11(12):2375-6
164. Kim YC, Guan KL. mTOR: a pharmacologic target for autophagy regulation. J Clin Invest. 2015 Jan;125(1):25-32
165. Wang R, Yu Z, Sunchu B, Shoaf J, Dang I, Zhao S, Caples K, Bradley L, Beaver LM, Ho E, Löhr CV, Perez VI. Rapamycin inhibits the secretory phenotype of senescent cells by a Nrf2-independent mechanism. Aging Cell. 2017 Jun;16(3):564-574
166. Wang R, Sunchu B, Perez VI. Rapamycin and the inhibition of the secretory phenotype. Exp Gerontol. 2017 Aug;94:89-92
167. Arriola Apelo SI, Lamming DW. Rapamycin: An InhibiTOR of Aging Emerges From the Soil of Easter Island. J Gerontol A Biol Sci Med Sci. 2016 Jul;71(7):841-9
168. Harrison DE, Strong R, Sharp ZD, Nelson JF, Astle CM, et al.R apamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature. 2009 Jul 16;460(7253):392-5
169. Keating R, Hertz T, Wehenkel M, Harris TL, Edwards BA et al. The kinase mTOR modulates the antibody response to provide cross-protective immunity to lethal infection with influenza virus. Nat Immunol. 2013 Dec;14(12):1266-76
170. Cohen J. Infectious disease. Immune suppressant unexpectedly boosts flu vaccine. Science. 2013 Oct 25;342(6157):413
171. Johnson SC, Kaeberlein M. Rapamycin in aging and disease: maximizing efficacy while minimizing side effects. Oncotarget. 2016 Jul 19;7(29):44876-44878
172. Blagosklonny MV. From rapalogs to anti-aging formula. Oncotarget. 2017; 8:35492-35507
173. Arriola-Apelo SI, Pumper CP, Baar EL, Cummings NE, Lamming DW. Intermittent administration of rapamycin extends the life span of female C57BL/6J mice. J Gerontol A Biol Sci Med Sci. 2016;71: 876–881.
174. http://www.fiercebiotech.com/biotech/novartis-offloads-phase-2-mtorc1-programs-to-puretech
175. Arriola Apelo SI, Neuman JC, Baar EL, Syed FA, Cummings NE et al. Alternative rapamycin treatment regimens mitigate the impact of rapamycin on glucose homeostasis and the immune system. Aging Cell. 2016 Feb;15(1):28-38
176. Lamming DW, Ye L, Katajisto P, Goncalves MD, Saitoh M, et al. Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity. Science 2012; 335(6076):1638–43
177. Foretz M, Guigas B, Bertrand L, Pollak M, Viollet B. Metformin: from mechanisms of action to therapies. Cell Metab. 2014 Dec 2;20(6):953-66
178. Kobilo T, Guerrieri D, Zhang Y, Collica SC, Becker KG, van Praag H. AMPK agonist AICAR improves cognition and motor coordination in young and aged mice. Learn Mem. 2014 Jan 17;21(2):119-26
179. Toedebusch RG, Ruegsegger GN, Braselton JF, Heese AJ, Hofheins JC, et al. AMPK agonist AICAR delays the initial decline in lifetime-apex Vo2 peak, while voluntary wheel running fails to delay its initialdecline in female rats. Physiol Genomics. 2016 Feb;48(2):101-15
180. McCarty MF. AMPK activation–protean potential for boosting healthspan. Age (Dordr). 2014;36(2):641-63
181. Marín-Aguilar F, Pavillard LE, Giampieri F, Bullón P, Cordero MD. Adenosine Monophosphate (AMP)-Activated Protein Kinase: a new target for nutraceutical compounds. Int J Mol Sci. 2017 Jan 29;18(2)
182. Bitterman JL, Chung JH. Metabolic effects of resveratrol: addressing the controversies. Cell Mol Life Sci. 2015 Apr;72(8):1473-88
183. Kulkarni SS, Cantó C. The molecular targets of resveratrol. Biochim Biophys Acta. 2015;1852(6):1114-23
184. Bonkowski MS, Sinclair DA. Slowing ageing by design: the rise of NAD(+) and sirtuin-activating compounds. Nat Rev Mol Cell Biol. 2016 Nov;17(11):679-690
185. Sauve AA, Youn DY. Sirtuins: NAD(+)-dependent deacetylase mechanism and regulation. Curr Opin Chem Biol. 2012 Dec;16(5-6):535-43
186. Grabowska W, Sikora E, Bielak-Zmijewska A. Sirtuins, a promising target in slowing down the ageing process. Biogerontology. 2017 Mar 3. doi: 10.1007/s10522-017-9685-9. [Epub ahead of print]
187. Watroba M, Szukiewicz D. The role of sirtuins in aging and age-related diseases. Adv Med Sci. 2016 Mar;61(1):52-62
188. Kupis W, Pałyga J, Tomal E, Niewiadomska E. The role of sirtuins in cellular homeostasis. J Physiol Biochem. 2016 Sep;72(3):371-80
189. Michan S. Calorie restriction and NAD+/sirtuin counteract the hallmarks of aging. Front Biosci (Landmark Ed). 2014 Jun 1;19:1300-19
190. Trammell SA, Weidemann BJ, Chadda A, Yorek MS, Holmes A, Coppey LJ, Obrosov A, Kardon RH, Yorek MA, Brenner C. Nicotinamide Riboside opposes type 2 diabetes and neuropathy in mice. Sci Rep. 2016 May 27;6:26933
191. Zhang H, Ryu D, Wu Y, Gariani K, Wang X et al. NAD+ repletion improves mitochondrial and stem cell function and enhances life span in mice. Science. 2016 Jun 17;352(6292):1436-43
192. Trammell SA, Schmidt MS, Weidemann BJ, Redpath P, Jaksch F, Dellinger RW, Li Z, Abel ED, Migaud ME, Brenner C. Nicotinamide riboside is uniquely and orally bioavailable in mice and humans. Nat Commun. 2016 Oct 10;7:12948
193. Shi W, Hegeman MA, van Dartel DA, Tang J, Suarez M, Swarts H, van der Hee B, Arola L, Keijer J. Effects of a wide range of dietary nicotinamide riboside (NR) concentrations on metabolic flexibility and white adipose tissue (WAT) of mice fed a mildly obesogenic diet. Mol Nutr Food Res. 2017 Feb 16. doi:10.1002/mnfr.201600878. [Epub ahead of print]
194. Hunter PM, Hegele RA. Functional foods and dietary supplements for the management of dyslipidaemia. Nat Rev Endocrinol. 2017 May;13(5):278-288
195. Thompson ME, Noel MB. Issues in Nutrition: Dietary Supplements. FP Essent. 2017 Jan;452:18-25
196. Piemontese L. Plant Food Supplements with Antioxidant properties for the treatment of chronic and neurodegenerative diseases: benefits or risks? J Diet Suppl. 2017 Jul 4;14(4):478-484
197. Pitkälä KH, Suominen MH, Bell JS, Strandberg TE. Herbal medications and other dietary supplements. A clinical review for physicians caring for older people. Ann Med. 2016 Dec;48(8):586-602
198. Rautiainen S, Manson JE, Lichtenstein AH, Sesso HD. Dietary supplements and disease prevention – a global overview. Nat Rev Endocrinol. 2016 Jul;12(7):407-20
199. Wibisono C, Probst Y, Neale E, Tapsell L. Impact of food supplementation on weight loss in randomised-controlled dietary intervention trials: a systematic review and meta-analysis. Br J Nutr. 2016 Apr;115(8):1406-14
200. Pattanittum P, Kunyanone N, Brown J, Sangkomkamhang US, Barnes J et al. Dietary supplements for dysmenorrhoea. Cochrane Database Syst Rev. 2016 Mar 22;3:CD002124
201. Moskalev A, Chernyagina E, Kudryavtseva A, Shaposhnikov M. Geroprotectors: a unified concept and screening approaches. Aging Dis. 2017 May 2;8(3):354-363
202. Aliper A, Belikov AV, Garazha A, Jellen L, Artemov A et al. In search for geroprotectors: in silico screening and in vitro validation of signalome-level mimetics of young healthy state. Aging (Albany NY). 2016 Sep 24;8(9):2127-2152
203. Moskalev A, Chernyagina E, Tsvetkov V, Fedintsev A, Shaposhnikov M et al. Developing criteria for evaluation of geroprotectors as a key stage toward translation to the clinic. Aging Cell. 2016 Jun;15(3):407-15
204. Sauer S, Plauth A. Health-beneficial nutraceuticals-myth or reality? Appl Microbiol Biotechnol. 2017 Feb;101(3):951-961
205. Liljeberg E, Andersson A, Lövestam E, Nydahl M. Incomplete descriptions of oral nutritional supplement interventions in reports of randomised controlled trials. Clin Nutr. 2017 Mar 25. pii: S0261-5614(17)30115-2
20.6 Wibisono C, Probst Y, Neale E, Tapsell L. Impact of food supplementation on weight loss in randomised-controlled dietary intervention trials: a systematic review and meta-analysis. Br J Nutr. 2016 Apr;115(8):1406-14
207. Fortmann SP, Burda BU, Senger CA, Lin JS, Whitlock EP. Vitamin and mineral supplements in the primary prevention of cardiovascular disease and cancer: An updated systematic evidence review for the U.S. Preventive Services Task Force. Ann Intern Med. 2013 Dec 17;159(12):824-34.
208. Hercberg S, Galan P, Preziosi P, Bertrais S, Mennen L, Malvy D, Roussel AM, Favier A, Briançon S. The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals. Arch Intern Med. 2004 Nov 22;164(21):2335-42
209. Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA. 2007 Feb 28;297(8):842-57
210. Rizos EC et al. Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis. JAMA. 2012 Sep 12;308(10):1024-33
211. Schwingshackl L, Boeing H, Stelmach-Mardas M, Gottschald M, Dietrich S et al. Dietary supplements and risk of cause-specific death, cardiovascular disease, and cancer: a systematic review and meta-analysis of primary prevention trials. Adv Nutr. 2017 Jan 17;8(1):27-39
212. Brown AC. Kidney toxicity related to herbs and dietary supplements: Online table of case reports. Part 3 of 5 series. Food Chem Toxicol. 2017 Sep;107(Pt A):502-519
213. Navarro VJ, Khan I, Björnsson E, Seeff LB, Serrano J, Hoofnagle JH. Liver injury from herbal and dietary supplements. Hepatology. 2017 Jan;65(1):363-373
214. Asher GN, Corbett AH, Hawke RL. Common herbal dietary supplement-drug interactions. Am Fam Physician. 2017 Jul 15;96(2):101-107
215. McCubrey JA, Lertpiriyapong K, Steelman LS, Abrams SL, Yang LV, et al. Effects of resveratrol, curcumin, berberine and other nutraceuticals on aging, cancer development, cancer stem cells and microRNAs. Aging (Albany NY). 2017 Jun 12;9(6):1477-1536
216. Pallauf K, Rimbach G, Rupp PM, Chin D, Wolf IM. Resveratrol and lifespan in model organisms. Curr Med Chem. 2016;23(41):4639-4680
217. Bhullar KS, Hubbard BP. Lifespan and healthspan extension by resveratrol. Biochim Biophys Acta. 2015 Jun;1852(6):1209-18
218. Singh CK, Liu X, Ahmad N. Resveratrol, in its natural combination in whole grape, for health promotion and disease management. Ann N Y Acad Sci. 2015 Aug;1348(1):150-60
219. Poulose SM, Thangthaeng N, Miller MG, Shukitt-Hale B. Effects of pterostilbene and resveratrol on brain and behavior. Neurochem Int. 2015 Oct;89:227-33
220. Kasiotis KM, Pratsinis H, Kletsas D, Haroutounian SA. Resveratrol and related stilbenes: their anti-aging and anti-angiogenic properties. Food Chem Toxicol. 2013 Nov;61:112-20
221. Assuncao M, Andrade JP. Protective action of green tea catechins in neuronal mitochondria during aging. Front Biosci (Landmark Ed). 2015 Jan 1;20:247-62
222. Kim J, Kim J, Shim J, Lee CY, Lee KW, Lee HJ. Cocoa phytochemicals: recent advances in molecular mechanisms on health. Crit Rev Food Sci Nutr. 2014;54(11):1458-72
223. Khurana S, Venkataraman K, Hollingsworth A, Piche M, Tai TC. Polyphenols: benefits to the cardiovascular system in health and in aging. Nutrients. 2013 Sep 26;5(10):3779-827
224. Gupta C, Prakash D. Phytonutrients as therapeutic agents. J Complement Integr Med. 2014 Sep;11(3):151-69
225. Tsuda T. Dietary anthocyanin-rich plants: biochemical basis and recent progress in health benefits studies. Mol Nutr Food Res. 2012 Jan;56(1):159-7
226. Pal S, Konkimalla VB. Hormetic Potential of Sulforaphane (SFN) in Switching Cells’ Fate Towards Survival or Death. Mini Rev Med Chem. 2016;16(12):980-95
227. Sikdar S, Papadopoulou M, Dubois J. What do we know about sulforaphane protection against photoaging? J Cosmet Dermatol. 2016 Mar;15(1):72-7
228. McCubrey JA, Lertpiriyapong K, Steelman LS, Abrams SL, Cocco L et al. Regulation of GSK-3 activity by curcumin, berberine and resveratrol: Potential effects on multiple diseases. Adv Biol Regul. 2017 May 26. pii:S2212-4926(17)30092-1
229. Shen LR, Parnell LD, Ordovas JM, Lai CQ. Curcumin and aging. Biofactors. 2013 Jan-Feb;39(1):133-40
230. Imai S, Guarente L. NAD+ and sirtuins in aging and disease. Trends Cell Biol. 2014 Aug;24(8):464-71
231. Barardo D, Thornton D, Thoppil H, Walsh M, Sharifi S et al. The DrugAge database of aging-related drugs. Aging Cell. 2017 Jun;16(3):594-597
232. Barardo DG, Newby D, Thornton D, Ghafourian T, de Magalhães JP, Freitas AA. Machine learning for predicting lifespan-extending chemical compounds. Aging (Albany NY). 2017 Jul 18;9(7):1721-1737
233. Mo C, Zhang W, Liu L, Wang L, Xiao H. High throughput screening technology and the small molecules modulating aging related signals. Comb Chem High Throughput Screen. 2012 Mar;15(3):242-52
234. Xu ZL, Gao H, Ou-Yang KQ, Cai SX, Hu YH. Establishment of a cell-based assay to screen regulators for Klotho gene promoter. Acta Pharmacol Sin. 2004 Sep;25(9):1165-70
235. Nakaya S, Mizuno S, Ishigami H, Yamakawa Y, Kawagishi H, Ushimaru T. New rapid screening method for anti-aging compounds using budding yeast and identification of beauveriolide I as a potent active compound. Biosci Biotechnol iochem.2012;76(6):1226-8
236. Lucanic M, Plummer WT, Chen E, Harke J, Foulger AC et al. Impact of genetic background and experimental reproducibility on identifying chemical compounds with robust longevity effects. Nat Commun. 2017 Feb 21;8:14256
237. Nadon NL, Strong R, Miller RA, Harrison DE. NIA Interventions Testing Program:investigating putative aging intervention agents in a genetically heterogeneous mouse model. EBioMedicine. 2017 Jul;21:3-4
238. Vaiserman A, Lushchak O. Implementation of longevity-promoting supplements and medications in public health practice: achievements, challenges and future perspectives. J Transl Med. 2017 Jul 20;15(1):160

Invia il tuo commento

Per favore inserisci il tuo nome

Inserisci il tuo nome

Per favore inserisci un indirizzo e-mail valido

Inserisci un indirizzo e-mail

Per favore inserisci il tuo messaggio

Dermakos © 2017 Tutti i diritti riservati

© 2015 Tecniche Nuove Spa • Tutti i diritti riservati. Sede legale: Via Eritrea 21 - 20157 Milano.
Capitale sociale: 5.000.000 euro interamente versati. Codice fiscale, Partita Iva e Iscrizione al Registro delle Imprese di Milano: 00753480151